Healthcare Net Income From Continuing Ops from 2010 to 2026

HCTI Stock  USD 0.30  0.03  11.11%   
Healthcare Triangle's Net Loss is decreasing with very volatile movements from year to year. Net Loss is predicted to flatten to about -5.6 M. For the period between 2010 and 2026, Healthcare Triangle, Net Loss quarterly trend regression had median of (5,811,376) and r-value of (0.08). View All Fundamentals
 
Net Loss  
First Reported
2015-12-31
Previous Quarter
-1.4 M
Current Value
-1.9 M
Quarterly Volatility
1.7 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Healthcare Triangle financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthcare Triangle's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 1.5 M or Selling General Administrative of 3.6 M, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0 or Days Sales Outstanding of 62.74. Healthcare financial statements analysis is a perfect complement when working with Healthcare Triangle Valuation or Volatility modules.
  
Build AI portfolio with Healthcare Stock
Check out the analysis of Healthcare Triangle Correlation against competitors.
For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.

Latest Healthcare Triangle's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Healthcare Triangle over the last few years. It is Healthcare Triangle's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Healthcare Triangle's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Very volatile
   Net Income From Continuing Ops   
       Timeline  

Healthcare Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(4,643,005)
Coefficient Of Variation(84.03)
Mean Deviation2,883,161
Median(5,811,376)
Standard Deviation3,901,410
Sample Variance15.2T
Range14.2M
R-Value(0.08)
Mean Square Error16.1T
R-Squared0.01
Significance0.76
Slope(62,978)
Total Sum of Squares243.5T

Healthcare Net Income From Continuing Ops History

2026-5.6 M
2025-5.4 M
2024-6 M
2023-11.9 M
2022-9.6 M
2021-6 M
20202.4 M

About Healthcare Triangle Financial Statements

Investors use fundamental indicators, such as Healthcare Triangle's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Healthcare Triangle's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Loss-5.4 M-5.6 M

Currently Active Assets on Macroaxis

When determining whether Healthcare Triangle offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthcare Triangle's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthcare Triangle Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthcare Triangle Stock:
Check out the analysis of Healthcare Triangle Correlation against competitors.
For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is there potential for Health Care Equipment & Supplies market expansion? Will Healthcare introduce new products? Factors like these will boost the valuation of Healthcare Triangle. Market participants price Healthcare higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Healthcare Triangle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(112.08)
Revenue Per Share
19.443
Quarterly Revenue Growth
0.192
Return On Assets
(0.27)
Return On Equity
(1.18)
The market value of Healthcare Triangle is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Triangle's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Triangle's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Healthcare Triangle's market value can be influenced by many factors that don't directly affect Healthcare Triangle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Triangle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Triangle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Healthcare Triangle's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.